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Abstract
Objective To evaluate whether risk assessment scales
can be used to identify patients who are likely to get
pressure ulcers.
Design Prospective cohort study.
Setting Two large hospitals in the Netherlands.
Participants 1229 patients admitted to the surgical,
internal, neurological, or geriatric wards between
January 1999 and June 2000.
Main outcome measure Occurrence of a pressure
ulcer of grade 2 or worse while in hospital.
Results 135 patients developed pressure ulcers
during four weeks after admission. The weekly
incidence of patients with pressure ulcers was 6.2%
(95% confidence interval 5.2% to 7.2%). The area
under the receiver operating characteristic curve was
0.56 (0.51 to 0.61) for the Norton scale, 0.55 (0.49 to
0.60) for the Braden scale, and 0.61 (0.56 to 0.66) for
the Waterlow scale; the areas for the subpopulation,
excluding patients who received preventive measures
without developing pressure ulcers and excluding
surgical patients, were 0.71 (0.65 to 0.77), 0.71 (0.64 to
0.78), and 0.68 (0.61 to 0.74), respectively. In this
subpopulation, using the recommended cut­off points,
the positive predictive value was 7.0% for the Norton,
7.8% for the Braden, and 5.3% for the Waterlow scale.
Conclusion Although risk assessment scales predict
the occurrence of pressure ulcers to some extent,
routine use of these scales leads to inefficient use of
preventive measures. An accurate risk assessment
scale based on prospectively gathered data should be
developed.
Introduction
Patients admitted to hospital or otherwise confined to a
bed, chair, or wheelchair are at risk from developing
pressure ulcers.This presents a huge burden for health
care in Western countries. In the Netherlands, more
than 1% of the total healthcare budget is spent on pre­
venting and treating pressure ulcers or the prolonged
hospital stay once a pressure ulcer has developed.Pres­
sure ulcers are the third costliest disorder, after cancer
and cardiovascular diseases.
1 In 1999, 8­10% of hospi­
tal patients in the Netherlands had pressure ulcers of
grade 2 or worse.
2 The proportion of patients newly
admitted to hospital that developed pressure ulcers
varied from 2.7% to 29.5%.
3–8 Preventive measures are
expensive and labour intensive: patients at risk of
developing pressure ulcers should be identified.
91 0
At least 40 risk assessment scales exist.
11 Most
reflect expert opinion, literature review, or adaptation
of an existing scale. Neither risk factors nor weights
attributed to them have been identified,using adequate
statistical techniques.
12 Only six risk assessment scales
have been tested for their predictive validity.
12 Of these
six, the Norton and Waterlow scales have been tested
twice and the Braden scale nine times. The results var­
ied, and little evidence of predictive value or accuracy
of the scales was available.
3 9 12 13–15 Moreover, most of
the studies had methodological limitations
12: they were
small and conducted in varying populations. Also, in
some studies the nurse was not blinded when doing
the scoring nor were the results adjusted to take
account of preventive measures.
Despite these shortcomings, the Braden and
Norton scales are recommended tools in North
American guidelines for the prevention of pressure
ulcers.
4 In the United Kingdom, the Waterlow and
Norton scales are the two scales most commonly
used,
14 and expensive preventive measures are taken
based on their outcome. Because the Norton,
16
Braden,
17 and Waterlow scales (www.awma.com.au/
pages/Guidelines.pdf),
10 can be viewed as a standard of
reference and are recommended in several practice
guidelines, we chose to evaluate their predictive value
in a prospective cohort of 1229 hospitalised patients.
Methods
The prevention and pressure ulcer risk score
evaluation study (prePURSE) is a prospective cohort
study that includes patients from the Utrecht
University Medical Centre and Eemland Hospital,
Amersfoort, the Netherlands. Between January 1999
and June 2000, patients admitted to the surgical, inter­
nal, neurological, and geriatric wards were asked to
participate in the study. Patients without pressure
ulcers, older than 18 years, and with an expected
admission of at least five days were eligible: a total of
6000 during the study period. Research nurses visited
each ward twice a week and asked eligible patients
admitted in the past 48 hours to participate. A quarter
(1536) of patients were visited, of whom 93.2% (1431)
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p a g e1o f5 BMJ VOLUME 325 12 OCTOBER 2002 bmj.comagreed to participate. Eventually, 80% of patients
(1229) had at least one follow up visit before discharge
(table 1). Although not strictly random, we enrolled an
unselected representative sample of patients.The study
was approved by the ethics committees of both hospi­
tals.
Data collection
A research nurse visited patients within 48 hours of
admission and once a week subsequently until they
developed a pressure ulcer, were discharged, or had
stayed in hospital for more than 12 weeks. A nurse
checked for the presence of pressure ulcers and
collected information on all risk factors included in the
risk assessment scales (table 2). The scales sum the
points for individual items into one overall score. A
threshold given by the original author of the scale
divides the patients into at risk or not at risk for devel­
oping pressure ulcers. At each visit, we collected infor­
mation on preventive measures.Attending nurses were
blinded for the observations by the research nurse.
Pressure ulcers were classified according to the four
grades of the European pressure ulcer advisory
panel.
10 Pressure ulcers of grade 2 or worse were
included.
10 Preventive measures were included if, at the
time the skin was inspected, the patient had a pressure
reducing mattress or bed or was repositioned regularly.
Statistical analysis
Patient's scores on the Norton, Braden, and Waterlow
scales were calculated for each visit. The ability of the
scales to predict whether pressure ulcers will develop
was determined from the area under the receiver oper­
ating characteristic curve, using SPSS.
18 19 The area
under the curve can range from 0.5 (no discrimination)
to 1.0 (perfect discrimination).
We carried out analyses each week using receiver
operating characteristic curves, but as most pressure
ulcers occurred in the first four weeks, we limited our
“per week analyses” to these. Similar analyses were car­
ried out excluding 57 patients who received preventive
measures without developing pressure ulcers. These
patients were excluded because it was impossible to
distinguish effective prevention from false positive
cases. In addition, similar analyses were performed
excluding 747 surgical patients, because these patients
may be at specifically high risk of developing pressure
ulcers.
20 We also combined data for 2190 patient weeks
and repeated the analyses.
To enable comparison with other studies, we calcu­
lated positive predictive value and negative predictive
value, as well as sensitivity and specificity, at
recommended cut­off points.
10 21 22
Results
A total of 135 (11%) patients developed pressure ulcers
while in hospital. Most pressure ulcers (129) developed
in the first four weeks. Overall, the weekly incidence of
patients with pressure ulcers was 6.2% (95% confi­
dence interval 5.2% to 7.2%). The maximum number
of follow up visits was 12, the median two.
A total of 57 patients received preventive measures
for 101 patient weeks in total. Patients receiving
preventive measures were about five years older than
those not receiving such measures, and a higher
proportion developed pressure ulcers (17.8% v 5.5%)
(table 3). Most patients at risk, according to the assess­
ment scales, did not receive preventive measures; some
patients considered not at risk did receive preventive
measures.
For all patients, the area under the curve for the
first week of follow up was 0.51 (0.44 to 0.58) for the
Norton scale, 0.52 (0.45 to 0.59) for the Braden scale,
and 0.60 (0.53 to 0.66) for the Waterlow scale (figure;
table 4). Results were similar when the 57 patients who
received preventive measures without developing pres­
sure ulcers were excluded. With both the 57 patients
who received preventive measures without developing
pressure ulcers and the 747 surgical patients excluded,
the areas under the curve were 0.69 (0.63 to 0.76), 0.70
(0.63 to 0.77), and 0.67 (0.61 to 0.73), respectively.
Excluding only the 747 surgical patients gave similar
results.In subsequent weeks,the areas under the curves
for the risk assessment scales did not differ substan­
tially between the subpopulation and the entire group
(table 4).
For all patients over all weeks (2190 patient weeks),
the areas under the curves were 0.56 (0.51 to 0.61),0.55
(0.49 to 0.60), and 0.61 (0.56 to 0.66). In the subpopu­
lation excluding patients who received preventive
measures without developing pressure ulcers (83
patient weeks) and surgical patients (752 patient
weeks), the areas under the curve were 0.71 (0.65 to
0.77), 0.71 (0.64 to 0.78), and 0.68 (0.61 to 0.74) (table
5; figure).
Because the areas under the curves indicated rela­
tively good performance of the risk assessment scales
in the subpopulation, we also calculated the positive
Table 1 Characteristics of participants who had at least one
follow up before discharge (n=1229). Values are numbers
(percentages) unless stated otherwise
Characteristic Value
Mean (SD) age (years) 60.1 (16.7)
Women 673 (54.8)
Hospital:
University Medical Centre Utrecht 783 (63.7)
Eemland Hospital 446 (36.3)
Ward:
Surgical 759 (61.8)
Internal medicine 275 (22.4)
Neurology 122 (9.9)
Geriatric 73 (5.9)
Table 2 Items included in the risk assessment scales
Items Norton scale
15 Braden scale
16 Waterlow scale
17
General physical condition Î
Mental state Î
Activity ÎÎ
Mobility ÎÎÎ
Incontinence ÎÎ
Sensory perception ÎÎ
Moisture (including incontinence) Î
Friction and shear Î
Nutrition ÎÎ
Build and weight relative to height Î
Visual skin type Î
Sex Î
Age Î
Anti­inflammatories or steroid use Î
Smoking Î
Orthopaedic surgery or fracture below waist Î
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and specificity of the scales at their respective cut­off
points (table 5).
Discussion
The three scales most commonly used to assess the risk
of developing pressure ulcers—the Norton, Braden,
and Waterlow scales—do not satisfactorily predict pres­
sure ulcer development in patients admitted to hospi­
tal. This may be because the risk assessment scales are
based on clinical observation and pathophysiological
insights, and not on adequate prospective or prognos­
tic research.
We observed patients once a week. Another study
found that the Braden scale was more useful between
48 and 72 hours after admission.
22 Guidelines about
preventing pressure ulcers advise assessing the risk on
admission and once a week afterwards,
23 at periodic
intervals,
4 or depending on changes in the condition of
the patient.
10 In hospitals, the interval between
assessments is usually a week.
Preventive measures
Preventive measures may modify the association
between scores on risk assessment scales and the
development of pressure ulcers. Only 10 patients
received preventive measures both at the visit during
which the skin was assessed and the previous visit.
Because patients who had not received preventive
measures at the previous visit could have had
preventive measures applied later that week, we
Table 3 Use of preventive measures in patients at risk of pressure ulcers
Characteristic
Preventive measures
Total (n=2190) Yes (n=101) No (n=2089)
Mean (SD) age (years) 67.2 (14.8) 61.9 (16.5) —
No (%) of weekly incidents
* 18 (13.4) 116 (86.6) 134
Mean (SD) score on risk assessment scale:
Braden 16.8 (4.3) 19.7 (3.1) —
Norton 14.5 (3.9) 16.9 (2.8) —
Waterlow 15.2 (5.3) 13.0 (4.7) —
No (%) of patient weeks at risk
†:
Braden 63 (8.9) 644 (91.1) 707
Norton 67 (7.8) 791 (92.2) 858
Waterlow 71 (4.6) 1458 (95.4) 1529
No (%) of patient weeks not at risk
†:
Braden 36 (2.5) 1405 (97.5) 1441
Norton 32 (2.5) 1258 (97.5) 1290
Waterlow 10 (2.4) 415 (97.6) 425
n=number of patient weeks, not patients.
*Data missing for one patient.
†Number of missing patient weeks: Braden 42, Norton 42, Waterlow 236.
Table 4 Areas under receiver operating characteristic curve (95% confidence intervals)
for the Norton, Braden, and Waterlow risk assessment scales for pressure ulcers at
each week of follow up of hospitalised patients
Week No Norton scale Braden scale Waterlow scale
All patients
1 1228 0.51 (0.44 to 0.58) 0.52 (0.45 to 0.59) 0.60 (0.53 to 0.66)
2 451 0.68 (0.59 to 0.77) 0.66 (0.56 to 0.76) 0.66 (0.56 to 0.76)
3 196 0.64 (0.50 to 0.79) 0.74 (0.59 to 0.88) 0.73 (0.60 to 0.86)
4 111 0.72 (0.52 to 0.92) 0.68 (0.48 to 0.88) 0.61 (0.46 to 0.76)
Subpopulation*
1 460 0.69 (0.63 to 0.76) 0.70 (0.63 to 0.77) 0.67 (0.61 to 0.73)
2 390 0.71 (0.61 to 0.81) 0.70 (0.60 to 0.81) 0.65 (0.55 to 0.75)
3 169 0.65 (0.49 to 0.82) 0.69 (0.51 to 0.87) 0.73 (0.60 to 0.87)
4 110 0.82 (0.67 to 0.97) 0.76 (0.57 to 0.95) 0.67 (0.54 to 0.80)
*Excluding patients given preventive measures who did not develop pressure ulcers (n=57) and surgical
patients (n=747).
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Receiver operating characteristic curves for Norton, Braden, and
Waterlow risk assessment scales in the first week, including all
patients (top) and for all weeks combined, in subpopulation
excluding surgical patients and patients with preventive measures
who did not develop pressure ulcers (bottom)
Table 5 Areas under operating receiver characteristic curves and test characteristics
(95% confidence intervals) for entire dataset for three risk assessment scales
*
Norton scale Braden scale Waterlow scale
All patients (n=2190 patient weeks)
Area under curve 0.56 (0.51 to 0.61) 0.55 (0.49 to 0.60) 0.61 (0.56 to 0.66)
Sensitivity (%) 46.2 (37.7 to 54.7) 43.5 (35.0 to 52.0) 89.5 (83.8 to 95.1)
Specificity (%) 60.4 (58.3 to 62.6) 67.8 (65.7 to 69.8) 22.4 (20.5 to 24.4)
Positive predictive value (%) 7.1 (5.5 to 9.1) 8.1 (6.2 to 10.3) 6.7 (5.5 to 8.0)
Negative predictive value (%) 94.5 (93.1 to 95.7) 94.9 (93.6 to 95.9) 97.2 (95.1 to 98.5)
Subpopulation (n=1355 patient weeks)
†
Area under curve 0.71 (0.65 to 0.77) 0.71 (0.64 to 0.78) 0.68 (0.61 to 0.74)
Sensitivity (%) 78.7 (66.3 to 88.1) 72.9 (59.7 to 83.6) 95.9 (86.0 to 99.5)
Specificity (%) 46.5 (43.7 to 49.3) 57.2 (55.4 to 60.0) 22.0 (19.5 to 24.5)
Positive predictive value (%) 7.0 (5.2 to 9.2) 7.8 (5.7 to 10.4) 5.3 (3.9 to 7.0)
Negative predictive value (%) 97.7 (96.1 to 98.8) 97.7 (96.3 to 98.7) 99.2 (97.0 to 99.9)
*Cut­off points: at risk if <16 on the Norton scale, <18 on the Braden scale, or >9 on the Waterlow scale.
†Excluding patient weeks with preventive measures without pressure ulcers and surgical patients.
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the time the skin was assessed. By doing so, however,
we also took into account an unknown number of
patients who received the measures as treatment for
their pressure ulcers. To assess the effect of these meas­
ures on the association between risk assessment scales
and development of pressure ulcers we excluded only
those patients who received measures and did not
develop pressure ulcers. The results did not differ from
those for the total population; preventive measures did
not affect the association between score on risk assess­
ment scales and the development of pressure ulcers.
We considered pressure reducing mattresses or beds
and regular repositioning to be preventive measures.
As there are no conclusive comparative studies on
effectiveness of these measures, we did not distinguish
between them.
Week of admission
The first and later weeks of follow up differed in
discriminative ability. This may be explained by differ­
ences in patients' characteristics over the period of
admission. In the first week of admission more than
half of the patients (747) had undergone surgery; sur­
gery is considered a risk factor for pressure ulcer
development.
20 Incidence of pressure ulcers in surgical
patients varies from 19% to 66%,
20 and almost a quar­
ter (23%) of the pressure ulcers which develop in the
hospital may be acquired intraoperatively,
24 but only
the Waterlow scale takes surgery into account.
Although the area under the curve for the Waterlow
scale was statistically significantly greater than 0.5, this
scale discriminated only marginally better than the
Norton and Braden scales. This may be due to an
imprecise definition of surgery or the weight attributed
to surgery, in the Waterlow scale. After we excluded
surgical patients, the area was greater and was
significant for all scales. These results may partly be
explained by the fact that we observed patients once a
week. Most patients undergoing surgery were in a rea­
sonable physical condition at admission (first observa­
tion) and therefore not at risk, according to the risk
assessment scales. It may well be that the scales would
have discriminated better immediately after surgery
rather than a week after admission. Intraoperatively
acquired pressure ulcers, however, still could not have
been predicted.Including imminent surgery as a factor
in the risk assessment might improve prediction.
The discriminative ability of the scales in all weeks
of follow up did not change greatly when surgical
patients were excluded. We combined the data of the
different weeks of follow up. The scales are able to pre­
dict whether or not a patient develops a pressure ulcer
in 70% of the cases. The positive predictive value of the
risk assessment scales, however, varied between 5.3%
and 7.8%: only 5% to 8% of the patients for whom the
risk assessment scales recommend receiving preven­
tive measures actually develop pressure ulcers.
Although the scales predict development of pressure
ulcers, to some extent, strict application of the scales
leads to inefficient use of preventive measures.
Previous studies
Although some earlier studies reported higher
sensitivity and specificity for the Norton and Braden
scales,
91 61 7 we have confidence in our results. We
defined pressure ulcers as grade 2 or worse. Older
lesions of the skin would still have been visible as a scab
at a subsequent visit. Consequently, no pressure ulcers
could have been missed. Also, the results of the earlier
studies may well have been flawed because preventive
measures were not taken into account.
14 Preventive
measures may have stopped pressure ulcers develop­
ing. Most preventive measures were taken in patients
who were not at risk, according to the risk assessment
scales. In fact, in only 67 (7.8%) of the patient weeks
which the Norton scale considered high risk,
preventive measures were given. Despite prevention,
eight patients developed pressure ulcers. Accordingly,
the performance of the Norton scale may have been
modified only in 6.9% (59) of the patient weeks at risk.
A similar outcome was found for the other two scales:
the effect of preventive measures was small.
As the incidence of pressure ulcers (6.2%) is low, it
may not be possible to improve much on the
prediction of pressure ulcers. Eventually, it may be
more effective to treat a grade 1 pressure ulcer imme­
diately than to try to “predict and prevent.”
Conclusion
The broadly advocated advice to use risk assessment
scales for pressure ulcers and to use the outcomes to
decide on preventive measures leads to ineffective and
inefficient treatment for most patients. Future research
should identify factors actually associated with the
development of pressure ulcers and evidence based
risk assessment scales should be constructed.
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What is already known on this topic
The incidence of pressure ulcers in hospitalised
patients varies between 2.7% and 29.5%
Guidelines for prevention of pressure ulcers base
the allocation of labour and resource intensive
measures on the outcome of risk assessment scales
Most risk assessment scales are based on expert
opinion or literature review and have not been
evaluated
The sensitivity and specificity of risk assessment
scales vary
What this study adds
The effectiveness of available risk assessment
scales is limited
Use of the outcome of risk assessment scales leads
to inefficient allocation of preventive measures
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